Endovenous Laser Ablation (EVLA)


EVLA is used to block off either main saphenous vein by passing a laser probe up the vein introduced through a puncture needle under local anaesthetic with ultrasound guidance. It has been in use for approximately 10 years in the USA and Europe. It was introduced into Australia by our group in 2002. Our results published in the Medical Journal of Australia and European Journal of Vascular Surgery show a low risk of complications and excellent medium-term results (to view the published article - click here). Both legs can be treated at the one session. Visible varicose veins are usually treated by ultrasound-guided sclerotherapy (UGS) at the same time and again some 2-4 weeks later when they have decreased in size.

What are the advantages and disadvantages for EVLA?



What should you do before EVLA?

What happens during EVLA?

What should you do after EVLA?

What can you expect following EVLA?

The following features are expected. They are not a cause for concern although they should be reported at review:

What are the possible complications from EVLA?

Complications can occur even with perfect technique.

Please Note

Medicare has restriction on the item number for Sclerotherapy (item 32500)

A maximum of 6 treatments in a 12 month period is permitted by Medicare. You may require more treatment sessions but there will be no further rebate from Medicare if within the 12 month cycle. Please note if you have had Endovenous Laser Ablation and/or Ultrasound Guided Sclerotherapy the restriction also applies as the same item number is used for all three procedures.

We advise you contact Medicare to enquire further. General Patient Enquiries - Phone 132 011

-Subject to change-